All News Bio Vitos Pharma AB

Equities

BIOVIT

SE0009320278

Market Closed - Nasdaq Stockholm Other stock markets 16:20:40 31/05/2024 BST			5-day change	1st Jan Change
0.133 ^SEK	-4.32%		-13.64%	-44.12%

02-14	Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-14	Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-14	CI
Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-14	CI
Bio Vitos Pharma Teams Up with KFUM Kalmar to Explore Benefits of Iron Succinate for Female Athletes	02-12	MT
KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer	02-12	AQ
KFUM Kalmar and Bio Vitos Pharma Sign Collaboration Agreement to Conduct Research Study on Succifer	02-12	CI
The European Patent Office EPO grants patent that is important to Bio Vitos Pharma	12-20	AQ
The European Patent Office EPO Grants Patent to Bio Vitos Pharma AB	12-20	CI
Hemcheck Sweden AB will Change its Ticker to BIOVIT from HEMC	12-06	CI
Hemcheck Sweden AB will Change its Name to Bio Vitos Pharma AB	12-06	CI
Hemcheck Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-16	CI
Hemcheck completes the transaction with Bio Vitos	20/10/23	AQ
Hemcheck Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30/08/23	CI
Hemcheck has received a first order from its distributor Astemed	15/05/23	AQ
Hemcheck Sweden AB Receives A First Order from Its Distributor Astemed	15/05/23	CI
Hemcheck Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2023	09/05/23	CI
Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement	04/05/23	AQ
Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)	26/04/23	AQ
Hemcheck Sweden Receives New Follow Up Order from the Foundation for Innovative New Diagnostics	26/04/23	CI
Hemcheck has received a first order from the university hospital Charité in Berlin	05/04/23	AQ
Hemcheck Sweden AB Receives First Order from the University Hospital Charité in Berlin	05/04/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Bio Vitos Pharma AB

Equities

BIOVIT

SE0009320278

All News

Filters